Press Releases bioXXmed AG

Equities

T5O

DE000A0KFRJ1

Market Closed - Xetra Other stock markets 16:36:01 10/05/2024 BST			5-day change	1st Jan Change
0.406 ^EUR	0.00%		-13.25%	-8.97%

2023	BioXXmed AG Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Centaur Pharmaceuticals Pvt Ltd increases sales with Woxheal® - ongoing open label marketing study in numerous Indian centres AG:	03/02/23	EQ
CytoTools AG : Notification and public disclosure of transactions by persons	09/03/22	EQ
CytoTools : Supervisory Board of CytoTools AG announces the retirement of the two members of the Board of Directors (91.7 KiB)	01/10/21	PU
CytoTools : Annual General Meeting of CytoTools AG votes for dismissal of all Supervisory Board members	30/09/21	EQ
CytoTools : Supervisory Board of CytoTools AG announces the retirement of the two members of the Management Board according to schedule	30/09/21	EQ
CytoTools : reports progress of DermaPro Phase III Study in Europe and provides operational status update (103.1 KiB)	29/09/21	PU
CytoTools : Reports Progress of DermaPro(R) Phase III Study in Europe and Provides Operational Status Update	29/09/21	EQ
CytoTools : postpones Annual General Meeting (132.6 KiB)	20/07/21	PU
CytoTools : cures resolution of 2020 Annual General Meeting with proposed capital increase (96.9 KiB)	30/06/21	PU
CytoTools : cures resolution of 2020 Annual General Meeting with proposed capital increase	29/06/21	EQ
CytoTools : Treatment numbers in India slightly above previous quarter (102.9 KiB)	23/06/21	PU
CytoTools Q1 Trading Update: Treatment numbers in India slightly above previous quarter despite significant pandemic impact	21/06/21	EQ
CytoTools : signs collaboration agreement to develop inhalation therapy for viral infections such as COVID-19 and influenza	26/04/21	EQ
CytoTools : with good marketing start for DPOCL in India despite noticeable pandemic-related restrictions	22/02/21	EQ
CytoTools : receives confirmation of efficacy of DPOCL also against influenza viruses (100.8 KiB)	21/12/20	PU
CytoTools : receives confirmation of efficacy of DPCOL also against influenza viruses	21/12/20	EQ
CytoTools : Supervisory Board expresses trust in the Management Board after AGM (99.6 KiB)	08/12/20	PU
CytoTools : Supervisory Board of CytoTools AG expresses trust in the Management Board after the Annual General Meeting	07/12/20	EQ
CytoTools AG : Notification and public disclosure of transactions by persons	18/11/20	EQ
CytoTools : subsidiary completes establishment of German production and starts own production of DPOCL in Europe for the first time	18/11/20	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases bioXXmed AG

Equities

T5O

DE000A0KFRJ1

Press Releases

Filters